金河生物(002688.SZ)控股股东金河控股完成减持 合计减持3%股份

Core Viewpoint - The controlling shareholder of Jinhe Biological has completed its share reduction plan, selling a total of 22.5631 million shares, which represents 3% of the company's total share capital after excluding repurchased shares [1] Group 1 - The share reduction took place between August 11, 2025, and September 1, 2025 [1] - The shares were sold through block trading and centralized bidding methods [1]